The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online

Industrial Minerals confirms historic high-grade Laverton gold results

Industrial Minerals has further confirmed the potential of its Laverton gold project in WA with a…

BPM Minerals identifies Beachcomber as major gold system

BPM Minerals has discovered three new gold lodes with recently completed RC drilling at the Beachcomber…
The Market Online Video

Money and Investing: Financially drained in Australia? Here’s what’s really going on

This week on Money and Investing, Mitch Olarenshaw and I break down why so many Australians are feeling financially exhausted and what you

Pioneer locks in USFS approval for large-scale Springfield drilling in ‘culmination’ of prep work

Pioneer has received approval from the USFS to execute its maiden drilling program at the Springfield…